VIVUS $12.30

down -0.24


17/5/2013 04:17 PM  |  NASDAQ : VVUS  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : -48% - VVUS has underperformed the S&P 500 by 73%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  2. Vivus up on heart drug study

    Investors Business Daily

  3. Vivus Stock Up On Qsymia Heart Disease Study

    Investors Business Daily

  4. Novo Nordisk Earnings Beat Views; Competition Looms

    Investors Business Daily

  5. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  6. Vivus fell 4.2% to 13.72

    Investors Business Daily

  7. Vivus Stock Drops On Downgrade; Rival Arena Rises

    Investors Business Daily

  8. Measuring Social Network Buzz Over Pharma Stocks

    YCharts

  9. Benzinga's M&A Chatter for Tuesday January 8, 2013

    Benzinga

  10. VIVUS Call Buying Hits Fever Pitch

    By SchaeffersResearch

  11. Vivus up on Qsymia shipments

    Investors Business Daily

  12. Mid-Day Market Update: SolarCity Wins Big, SunPower Continues its Fall

    Benzinga

  13. Mid-Morning Market Update: Markets Giving Back Some Gains, Big ...

    Benzinga

  14. Vivus Stock Jumps On Latest Qsymia Shipment Numbers

    Investors Business Daily

  15. Benzinga's Top Pre-Market Gainers

    Benzinga

  16. Mid-Afternoon Market Update: Markets Rally Further, VIVUS Remains Down

    Benzinga

  17. Mid-Day Market Update: Markets Continue Rally, Dole Falls

    Benzinga

  18. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  19. Vivus

    Investors Business Daily

  20. Mid-Morning Market Update: Rite Aid Rallies, New York Stock ...

    Benzinga

  21. VIVUS Shares Edge Higher as Express Scripts Adds Qsymia to ...

    Benzinga

  22. Vivus Rallies on Prescription Increase

    Benzinga

  23. Vivus Soars On Qsymia Anti-Obesity Drug Prescriptions

    Investors Business Daily

  24. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga

  25. Mid-Day Market Update: Compuware Rises; Nam Tai Electronics Drops

    Benzinga

  26. Mid-Morning Market Update: Caribou Bought Out; Clearwire Plummets

    Benzinga

  27. Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX

    GuruFocus

  28. Weekly Guru Bargains Highlights: CIG, PWE, VVUS, EBR, ATHN

    GuruFocus

  29. Fat Chance: The Vivus Diet Pill Has Skinny Sales

    YCharts

  30. Acadia Pharma Rockets Higher on Study Results

    Benzinga

  31. VIVUS Initiates Qsymia Get Started! Free Trial Offer Program

    Benzinga

  32. Vivus

    Investors Business Daily

  33. Vivus Stock Soars As Aetna Adds Qsymia To Coverage

    Investors Business Daily

  34. Mid-Morning Market Update: Markets Largely Flat; Hostess to ...

    Benzinga

  35. Analyst Downgrades: VIVUS, Paychex, and Tyco International

    By SchaeffersResearch

  36. Mid-Morning Market Update: Markets Start to Recover; DryShips ...

    Benzinga

  37. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  38. Vivus Study Finds Significant Improvements in Patients with ...

    Benzinga

  39. Futures Flat, Euro Falls Ahead of Central Banks

    Benzinga

  40. VIVUS' Dismal Earnings Don't Deter Call Players

    By SchaeffersResearch

  41. Vivus misses, launches drug

    Investors Business Daily

  42. Vivus Earnings Miss Estimates; Arena Waits In Wings

    Investors Business Daily

  43. Mid-Morning Market Update: A Nation Votes, Markets Rise

    Benzinga

  44. Futures Rise on Election Day

    Benzinga

  45. Passport's John Burbank Boosts VIVUS Stake to 8.5 Pct of Company

    GuruFocus

  46. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  47. CHMP Recommends Against Marketing Authorization Application for ...

    Benzinga

  48. Who Needs Diet and Exercise? Health Plans Cover New Vivus Obesity Drug

    YCharts

  49. Stock Futures Point to Muted Open Ahead of Data with JP Morgan ...

    At Market Intelligence Center

  50. A Peek Into The Market Before The Trading Starts

    Benzinga

  51. VIVUS Class Action Lawsuit Dismissed

    Benzinga

  52. Option Volume Briefs: Bears Go Back to the VIVUS Well

    By SchaeffersResearch

  53. Analyst Downgrades: VIVUS, Citrix Systems, and Questcor ...

    By SchaeffersResearch

  54. Stocks Finish Mixed on Late Selling Spree with KB Home (KBH) and ...

    At Market Intelligence Center

  55. VIVUS Bearish Option Volume Spikes

    By SchaeffersResearch

  56. Vivus expects EU rejection

    Investors Business Daily

  57. Vivus (VVUS) Loses 10.7% After Warning EU May Reject Anit-Obesity Drug

    At Market Intelligence Center

  58. Benzinga Mid-Afternoon Market Update

    Benzinga

  59. Stocks Set for Higher Start with Apple (AAPL) and KB Home (KBH) on ...

    At Market Intelligence Center

  60. Benzinga Mid-Day Market Update

    Benzinga

  61. Vivus Expects EU To Reject Diet Drug, Shares Fall

    Investors Business Daily

  62. Vivus Dives 11% After Warning EU May Not Back Obesity Drug

    FOXBusiness

  63. All Eyes On Vivus As Weight Loss Drug Hits Market

    YCharts

  64. A Peek Into The Market Before The Trading Starts

    Benzinga

  65. Short Sellers Shy Away from Biotech Firms

    Benzinga

  66. Short Interest in Biotech Firms on the Rise

    Benzinga

  67. Weekly Top Insider Buys: IRM, JCP, APU, CAB, VVUS

    GuruFocus

  68. Health Care Sector Wrap

    FOXBusiness

  69. What Slims Down Fastest After Diet Drugs Are Approved by he FDA? ...

    YCharts

  70. Stock Futures Point to Quiet Open with Facebook (FB) and Marvell ...

    At Market Intelligence Center

  71. Social Media Outlook for Friday August 17 (FL, OPLK, VVUS, MAS)

    Benzinga

  72. Benzinga's Top Downgrades

    Benzinga

  73. A Peek Into The Market Before The Trading Starts

    Benzinga

  74. Short Sellers Shy Away from Biotech Firms

    Benzinga

  75. Health Care Sector Wrap

    FOXBusiness

  76. VIVUS Inc. Reports Operating Results (10-Q)

    GuruFocus

  77. Health Care Sector Wrap

    FOXBusiness

  78. After-Hours: Vivus Shares Down Following Earnings Update

    Benzinga

  79. Weekly CEO Sells Highlight: Splunk Inc, eBay Inc, Skyworks ...

    GuruFocus

  80. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  81. Weekly CFO Sells Highlight: PII, ASNA, FIO, VVUS, AFFY

    GuruFocus

  82. Weekly CEO Sells Highlight: GTx, Inc, VIVUS, Inc, Time Warner Inc.

    GuruFocus

  83. VIVUS Inc. (VVUS) CEO Leland F Wilson sells 100,000 Shares

    GuruFocus

  84. VIVUS Inc. (VVUS) VP, Finance and CFO Timothy E Morris sells ...

    GuruFocus

  85. The Short Case for Vivus

    GuruFocus

  86. Health Care Sector Wrap

    FOXBusiness

  87. Social Media Outlook for Thursday July 19 (SWKS, EBAY, MS, CTRP)

    Benzinga

  88. Stocks Get Lift from Data, Earnings with Intel (INTC) and Vivus ...

    At Market Intelligence Center

  89. Vivus (VVUS) Gains 11% After FDA Approves Weight Loss Drug

    At Market Intelligence Center

  90. Stocks Futures Point to Soft Start Ahead of More Testimony, ...

    At Market Intelligence Center

  91. UPDATE: Rodman & Renshaw Reiterates Market Outperform Rating, ...

    Benzinga

  92. Wednesday Market Movers

    Benzinga

  93. FDA Gives Nod to Vivus' Weight Loss Drug

    FOXBusiness

  94. Vivus Stock Jumps 12.5% On Drug Approval

    Investors Business Daily

  95. VIVUS, Air Methods Corporation Among Stocks Gapping Up Wednesday

    FOXBusiness

  96. Benzinga's Top Upgrades

    Benzinga

  97. Stocks Hold Gains on Positive Earnings with Mattel (MAT) and ...

    At Market Intelligence Center

  98. FDA Approves Vivus Weight-Management Drug Qsymia

    Benzinga

  99. Baidu, Broadcom Among Stocks Down on Above-average Volume Tuesday

    FOXBusiness

  100. Vivus (VVUS) Gains 6% Ahead of FDA Ruling

    At Market Intelligence Center
People viewing VVUS also viewed: , , , , , ,
Marketplace
Trading Center